公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2010 | CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells | Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; TSUNG-HAO LIU ; Hou D.-R.; PEI-JER CHEN ; ANN-LII CHENG | Oncogene | 148 | 139 | |
2023 | Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective | TUNG-HUNG SU ; CHIH-HORNG WU ; TSUNG-HAO LIU ; CHENG-MAW HO ; CHUN-JEN LIU | Clinical and molecular hepatology | 8 | 6 | |
2019 | Considerations of heterogeneity in clinical trials for hepatocellular carcinoma | TSUNG-HAO LIU ; YU-YUN SHAO ; LI-CHUN LU ; Ying-Chun Shen ; CHIUN HSU ; ZHONG-ZHE LIN ; CHIH-HUNG HSU ; ANN-LII CHENG | Expert Review of Gastroenterology and Hepatology | 5 | 7 | |
2019 | Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma | LI-CHUN LU ; CHIUN HSU ; YU-YUN SHAO ; Chao Y.; Yen C.-J.; I-LUN SHIH ; Hung Y.-P.; Chang C.-J.; Ying-Chun Shen ; JHE-CYUAN GUO ; TSUNG-HAO LIU ; CHIH-HUNG HSU ; ANN-LII CHENG | Liver Cancer | 46 | 44 | |
2019 | Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma | YU-YUN SHAO ; TSUNG-HAO LIU ; CHIUN HSU ; LI-CHUN LU ; YING-CHUN SHEN ; ZHONG-ZHE LIN ; ANN-LII CHENG ; CHIH-HUNG HSU | Liver International | 56 | 58 | |
2022 | Immune checkpoint inhibitors for hepatocellular carcinoma - A game changer in treatment landscape | TSUNG-HAO LIU ; YING-CHUN SHEN ; ANN-LII CHENG | Journal of the Formosan Medical Association = Taiwan yi zhi | 3 | 2 | |
2019 | Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment | LI-CHUN LU ; Lee, Yi Hsuan; Chang, Chun Jung; CHIA-TUNG SHUN ; Fang, Chih Yeu; YU-YUN SHAO ; TSUNG-HAO LIU ; ANN-LII CHENG ; CHIH-HUNG HSU | Liver Cancer | 45 | 41 | |
2021 | It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade | TSUNG-HAO LIU ; YU-YUN SHAO ; CHIH-HUNG HSU | Journal of the Formosan Medical Association | 7 | 9 | |
2021 | Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy | YING-CHUN SHEN ; Yeh C.-P.; YUNG-MING JENG ; CHIUN HSU ; CHIH-HUNG HSU ; ZHONG-ZHE LIN ; YU-YUN SHAO ; LI-CHUN LU ; TSUNG-HAO LIU ; CHIEN-HUNG CHEN ; ANN-LII CHENG | Cancers | 2 | 2 | |
2010 | Minimum cycle bases of weighted outerplanar graphs | TSUNG-HAO LIU ; HSUEH-I LU | Information Processing Letters | 3 | 1 | |
2009 | Minimum cycle bases of weighted outerplanar graphs | TSUNG-HAO LIU ; HSUEH-I LU | Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) | 1 | 0 | |
2016 | Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma | YU-YUN SHAO ; TSUNG-HAO LIU ; Lee, Ying-Hui; CHIH-HUNG HSU ; ANN-LII CHENG | J. Gastroenterol. Hepatol. | 26 | 24 | |
2020 | Novel systemic therapy for hepatocellular carcinoma | Dong Y.; TSUNG-HAO LIU ; Yau T.; CHIUN HSU | Hepatology International | 13 | 11 | |
2019 | Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study | MENG-RUI LEE ; KAI-LUN YU ; HUNG-YANG KUO ; TSUNG-HAO LIU ; JEN-CHUNG KO ; JAW-SHIUN TSAI ; JANN-YUAN WANG | Scientific Reports | 16 | 13 | |
2021 | Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma | Chen, Ching-Tso; TSUNG-HAO LIU ; YU-YUN SHAO ; KAO-LANG LIU ; PO-CHIN LIANG ; ZHONG-ZHE LIN | International journal of molecular sciences | 16 | 8 | |
2023 | Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma | BANG-BIN CHEN ; PO-CHIN LIANG ; TIFFANY TING-FANG SHIH ; TSUNG-HAO LIU ; YING-CHUN SHEN ; LI-CHUN LU ; ZHONG-ZHE LIN ; CHIUN HSU ; CHIH-HUNG HSU ; ANN-LII CHENG ; YU-YUN SHAO | European radiology | 17 | 13 | |
2010 | Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3 | Chen K.-F.; Tai W.-T.; TSUNG-HAO LIU ; HSIANG-PO HUANG ; Lin Y.-C.; Shiau C.-W.; Li P.-K.; PEI-JER CHEN ; ANN-LII CHENG | Clinical Cancer Research | 147 | 145 | |
2018 | Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure | TSUNG-HAO LIU ; CHIH-HUNG HSU ; YU-YUN SHAO | Liver Cancer | 3 | 2 | |
2010 | Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation | Chen K.-F.; Yu H.-C.; TSUNG-HAO LIU ; SHOEI-SHENG LEE ; PEI-JER CHEN ; ANN-LII CHENG | Journal of Hepatology | 68 | 67 |